InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,214.11
(
-1.06%
)

Replies to post #137 on Ligand Pharma Inc Roche Contingent Value Rights (LGNDZ)

Replies to #137 on Ligand Pharma Inc Roche Contingent Value Rights (LGNDZ)

surf1944

07/25/12 8:44 AM

#138 RE: surf1944 #137

7:17AM Ligand Pharma partner GlaxoSmithKline (GSK) announces priority review from FDA for supplemental new drug application for Promacta for the treatment of thrombocytopenia in adult patients with chronic hepatitis C infection (LGND) 17.64 :